Xencor Inc.

Last updated September 27, 2026

Organization details

Legal name
Xencor Inc.
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2834 — Pharmaceutical Preparations
Jurisdiction of incorporation
Delaware
Headquarters city
Pasadena
Headquarters state / province
California
Headquarters country
United States
Fiscal year end
December
Ticker symbol
XNCR
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001326732
EIN
20-1622502

Board of directors

Chief executives

Bassil I. Dahiyat · PRESIDENT & CEO
Dates unknown

Director election results

Annual meeting of June 16, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

5 of this board's directors also sit on 6 other boards. 6 are in the same sector.

Network of Xencor Inc.'s board connections ALX Oncology Holdings Inc. ALX Oncology Holdings... Kodiak Sciences Inc Kodiak Sciences Inc Neurocrine Biosciences Inc. Neurocrine Biosciences... Neurogene Inc. Neurogene Inc. NextCure Inc. NextCure Inc. TScan Therapeutics Inc. TScan Therapeutics Inc... Barbara Klencke Barbara Klencke Bassil I. Dahiyat Bassil I. Dahiyat Ellen Feigal Ellen Feigal Kevin Charles Gorman Kevin Charles Gorman Todd E. Simpson Todd E. Simpson Xencor Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$3,900,463
18 sales by 9 insiders
Date Insider Transaction Shares Price Value
Jun 18, 2026 Ellen Feigal Director Open-market sale −6,843 $13.06 $89,370
Jun 16, 2026 Raymond Joseph Deshaies Director Grant or award +10,302 — —
Jun 16, 2026 Ellen Feigal Director Grant or award +10,302 — —
Jun 16, 2026 Kevin Charles Gorman Director Grant or award +10,302 — —
Jun 16, 2026 Kurt A. Gustafson Director Grant or award +10,302 — —
Jun 16, 2026 Barbara Klencke Director Grant or award +10,302 — —
Jun 16, 2026 Alan Bruce Montgomery Director Grant or award +10,302 — —
Jun 16, 2026 Richard J. Ranieri Director Grant or award +10,302 — —
Jun 16, 2026 Todd E. Simpson Director Grant or award +10,302 — —
Jun 15, 2026 Kevin Charles Gorman Director Open-market sale −7,527 $12.31 $92,657
Jun 15, 2026 Kurt A. Gustafson Director Open-market sale −5,474 $12.31 $67,385
Jun 15, 2026 Richard J. Ranieri Director Open-market sale −5,474 $12.31 $67,385
Jun 15, 2026 Alan Bruce Montgomery Director Open-market sale −5,064 $12.31 $62,338
Apr 10, 2026 Cornelissen Bart Jan Officer (SR. VICE PRESIDENT & CFO) Open-market sale −3,499 $12.29 $43,003
Mar 6, 2026 Desjarlais John R Officer (SR. VICE PRESIDENT & CSO) Open-market sale −2,502 $11.02 $27,572

Organizations in the same sector, closest in location and size first.

Questions about Xencor Inc.

Who is the CEO of Xencor Inc.?

Bassil I. Dahiyat is Xencor Inc.'s PRESIDENT & CEO.

How many directors are on Xencor Inc.'s board?

Xencor Inc.'s board has 10 directors: Alan Bruce Montgomery, Barbara Klencke, Bassil I. Dahiyat, Dagmar Rosa-Bjorkeson, Ellen Feigal, Kevin Charles Gorman, Kurt A. Gustafson, Raymond Joseph Deshaies, Richard J. Ranieri and Todd E. Simpson.

Are Xencor Inc. insiders buying or selling shares?

Over the last 12 months, Xencor Inc. insiders made no open-market purchases and sold $3.9 million of shares in 18 sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="xencor-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.